Compounded semaglutide and tirzepatide subscriptions

Vytora Health review

Vytora lists compounded semaglutide and tirzepatide with consultation, supplies and messaging. I would compare the written three-month total rather than the largest monthly label: semaglutide’s selected control calls $447 both a monthly figure and the three-month total. Tirzepatide also has a homepage-versus-product monthly-price discrepancy.

Check your care options.

Confirm the medication, clinical access and recurring bill for your own plan.

Visit Vytora HealthOfficial provider website. No affiliate relationship is currently listed.

A fit for

Self-pay readers who will reconcile the selected invoice, actual prescription and renewal agreement before buying.

  • Separate semaglutide and tirzepatide product pages identify compounded prescriptions.
  • Selected three-month controls state total charges.
  • Consultation, supplies and unlimited messaging are advertised.

Tradeoffs to understand

People expecting every displayed monthly figure to be consistent, a verified branded prescription or an unconditional medication refund.

  • Monthly labels conflict across selected controls and homepage FAQs.
  • Exact preparation, supplied quantities and shipment cadence need confirmation.
  • Shipping-charge language and nonapproval refund stages remain unclear.
In this review

Keep the three-month total beside the monthly label

Semaglutide’s monthly panel shows $179. Selecting three months produces a $447 three-month total but also labels $447 as per month; its FAQ instead describes $149 per month on that plan. I would obtain the selected invoice rather than silently repair the interface and assume the billing system agrees. [1]

Tirzepatide’s product panel and FAQ show $249 month-to-month, while the homepage FAQ says $199. Its three-month control states $599 total with a $199 monthly annotation, which is not exact arithmetic. These are current public inconsistencies, not proof of a universally available lower rate. [2] [3]

Identify what is supplied and when it arrives

The product pages expressly describe compounded injections, not FDA-approved finished products. They do not establish the complete selected formulation, concentration, vial count or actual dispensing assignment. A three-month billing period does not establish that the entire supply ships in one parcel. Confirm those details before comparing prices. [1] [2]

The site also links brand-name cards while its product disclaimer says it does not offer brand-name products. I would not infer a verified Mounjaro or Zepbound order from those cards. Compounded preparations do not inherit approved-brand trial results, and patient-specific compounding conditions still apply after shortage resolution. [1] [3] [8] [9]

Resolve cancellation before the first automatic renewal

The product FAQs call these recurring subscriptions: the card is charged each billing cycle until cancellation through support. They do not define a precise notice period or promise a prorated refund. Ask when the next charge occurs and when a renewal becomes committed. [1] [2]

The complete refund policy says all sales are final and prescription products cannot be returned for reuse or resale. It invites filling-error reports without stating an automatic refund or replacement. The public terms do not settle medical-nonapproval charges or a pre-preparation cancellation schedule. Obtain those stages before paying. [5] [7]

Value follow-up separately from delivery promises

The package advertises consultation, supplies, provider messaging and a progress portal. The care page describes responses from the actual provider, but no guaranteed reply interval or scheduled nutrition appointment is established. Ask what follow-up can actually be booked and whether required tests cost extra. [1] [2] [4]

Free-shipping claims conflict with the shipping policy’s checkout-charge language. That policy states two to three business days processing and average four to twelve business days shipping, with delays possible. Confirm the actual charge, service eligibility and pharmacy-specific storage instructions rather than rely on generic warm-shipment assurances or nationwide marketing. [6] [7]

Understanding the cost

Semaglutide monthly $179; three-month control says $447 total but labels $447/month while FAQ says $149/month. Tirzepatide product monthly $249 versus homepage FAQ $199; selected three-month total $599, annotated $199/month. Confirm invoice and renewal, not rounded annotations.

Build your cost estimate

Sources

  1. Vytora: semaglutide and selected three-month billing
  2. Vytora: tirzepatide selected plans
  3. Vytora: catalogue and homepage pricing FAQ
  4. Vytora: messaging, portal and refill claims
  5. Vytora: complete prescription refund policy
  6. Vytora: processing, delivery and shipping charges
  7. Vytora: platform, clinical entities and eligibility terms
  8. FDA: compounded drugs and premarket approval limits
  9. FDA: patient-specific GLP-1 compounding conditions after shortage resolution

This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.

Affiliate partner

Before you go

Explore this option
Continue to your original choiceWe may earn a commission if you choose our partner. These services may differ in products, fees and clinical access.